Corlieve Therapeutics
Developing neurological disease treatments
- B2B
About Corlieve Therapeutics
Biotechnology company dedicated to developing new treatments for severe neurological disorders, operating as a subsidiary of UniQure
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2019
- Website
- corlieve.com
Corlieve Therapeutics at a glance
Corlieve Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Corlieve Therapeutics was founded in 2019.
Corlieve Therapeutics has 1–10 employees.
Frequently asked questions about Corlieve Therapeutics
How many employees does Corlieve Therapeutics have?
Corlieve Therapeutics has 1–10 employees.
Where is Corlieve Therapeutics headquartered?
Corlieve Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like Corlieve Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies